AMERICAN SHARED HOSPITAL SERVICES Increase Decrease In Operating Lease Liability
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Increase Decrease In Operating Lease Liability of -$248.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$122.00K.
- AMERICAN SHARED HOSPITAL SERVICES increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$126.00K.
- AMERICAN SHARED HOSPITAL SERVICES increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$40.00K.
- AMERICAN SHARED HOSPITAL SERVICES increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$66.00K.
- AMERICAN SHARED HOSPITAL SERVICES increase decrease in operating lease liability for fiscal 2025 was -$285.00K.
- AMERICAN SHARED HOSPITAL SERVICES increase decrease in operating lease liability for fiscal 2024 was -$228.00K.
- AMERICAN SHARED HOSPITAL SERVICES increase decrease in operating lease liability for fiscal 2023 was $0.00.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$248.00K 10-Q · filed 2026-08-13 | -$288.00K derived: sum of 3 quarters · filed 2026-08-13 | -$354.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$126.00K 10-Q · filed 2026-05-14 | -$166.00K derived: sum of 2 quarters · filed 2026-05-14 | -$232.00K derived: sum of 3 quarters · filed 2026-05-14 | -$254.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$40.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | -$106.00K derived: sum of 2 quarters · filed 2026-03-31 | -$128.00K derived: sum of 3 quarters · filed 2026-08-13 | -$285.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$66.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16 | -$88.00K derived: sum of 2 quarters · filed 2026-08-13 | -$245.00K 10-Q/A · filed 2026-01-16 | -$254.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$179.00K 10-Q · filed 2026-08-13 | -$188.00K derived: sum of 3 quarters · filed 2026-08-13 | -$372.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$157.00K 10-Q · filed 2026-05-14 | -$166.00K derived: sum of 2 quarters · filed 2026-05-14 | -$350.00K derived: sum of 3 quarters · filed 2026-05-14 | -$364.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$9.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | -$193.00K derived: sum of 2 quarters · filed 2026-03-31 | -$207.00K derived: sum of 3 quarters · filed 2026-03-31 | -$228.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$184.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16 | -$198.00K derived: sum of 2 quarters · filed 2026-01-16 | -$219.00K 10-Q/A · filed 2026-01-16 | $46.00K derived: sum of 4 quarters · filed 2026-01-16 |
| 2024-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$35.00K 10-Q · filed 2025-08-13 | $230.00K derived: sum of 3 quarters · filed 2025-08-13 | $166.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$21.00K 10-Q · filed 2025-05-15 | $244.00K derived: sum of 2 quarters · filed 2025-05-15 | $180.00K derived: sum of 3 quarters · filed 2025-05-15 | $82.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $201.00K derived: sum of 2 quarters · filed 2025-04-04 | $103.00K derived: sum of 3 quarters · filed 2025-04-04 | $0.00 10-K · filed 2025-04-04 |
| 2023-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$162.00K derived: sum of 2 quarters · filed 2024-11-14 | -$265.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$201.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$103.00K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |